metabolomic

Untargeted metabolomic profiling of serum and urine in kidney cancer: a non-invasive approach for biomarker discovery

Publication date: July 2025

Broadband Collision‑Induced Dissociation Mass Spectrometry Imaging

Publication date: July 2025

Metabolomic profiling of human bladder tissue extracts using NMR and LDI‑MS for biomarker discovery

Publication date: January 2024

Untargeted metabolomics of bladder tissue using liquid chromatography and quadrupole time-of-flight mass spectrometry for cancer biomarker detection

Publication date: January 2024

Untargeted metabolomics of bladder tissue using liquid chromatography‑ultrahigh‑resolution mass spectrometry for cancer biomarker detection

Publication date: March 2024

Monoisotopic silver nanoparticles‑based mass spectrometry imaging of human bladder cancer tissue: Biomarker discovery

Publication date: December 2022

Metabolomic and elemental profiling of blood serum in bladder cancer

Publication date: September 2022

Untargeted ultra‑high‑resolution mass spectrometry metabolomic profiling of blood serum in bladder cancer

Publication date: September 2022

Metabolomic and elemental profiling of human tissue in kidney cancer

Publication date: March 2021

Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer

Publication date: July 2020